Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 19/20 | 0.57 |
| ▸ | PIK3CG | P48736 | 13/20 | 0.57 |
| ▸ | PIK3R1 | P27986 | 11/20 | 0.57 |
| ▸ | PIK3CB | P42338 | 11/20 | 0.57 |
| ▸ | PIK3CA | P42336 | 9/20 | 0.57 |
| ▸ | BCL2 | P10415 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19251416 | 0.80 | PIK3CD (0.48) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19252657 | 0.80 | PIK3CD (0.48) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19254016 | 0.80 | PIK3CD (0.55) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19251446 | 0.80 | PIK3CD (0.55) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19254021 | 0.76 | PIK3CD (0.40) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19251430 | 0.76 | PIK3CD (0.61) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19251447 | 0.76 | PIK3CD (0.54) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19254014 | 0.76 | PIK3CD (0.61) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19254003 | 0.76 | PIK3CD (0.54) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA | |
| SCHEMBL19251438 | 0.76 | PIK3CD (0.63) | PIK3CDPIK3CGPIK3R1PIK3CBPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017133655-A1 | BENZOTHIAZINE AND BENZOTHIADIAZINE COMPOUNDS AND PREPARATION AND USE | 浙江大学 | 2017-08-10 | — | — | WO | disclosed |